Consumption of an omega-3 fatty acids product, INCELL AAFA™, reduced side-effects of CPT-11 (irinotecan) in mice
2002

Omega-3 Fatty Acids Reduce Side Effects of Cancer Drug in Mice

Sample size: 40 publication 10 minutes Evidence: moderate

Author Information

Author(s): Hardman W E, Moyer M P, Cameron I L

Primary Institution: Pennington Biomedical Research Center, Louisiana State University

Hypothesis

Can the omega-3 fatty acid product INCELL AAFA™ reduce the side effects of CPT-11 chemotherapy in mice?

Conclusion

The study found that a diet including 2% AAFA™ significantly reduced the side effects of CPT-11 treatment in mice.

Supporting Evidence

  • 2% AAFA™ in the diet decreased apoptotic figures in the duodenal crypts.
  • Consumption of AAFA™ improved white blood cell counts.
  • 2% AAFA™ significantly decreased liver PGE2 levels.

Takeaway

Feeding mice a special omega-3 product helped them feel better and have fewer side effects from a cancer drug.

Methodology

Mice were divided into groups and fed diets with varying amounts of AAFA™ before receiving CPT-11 chemotherapy, followed by analysis of blood and tissue samples.

Potential Biases

Potential bias due to funding from the manufacturer of the omega-3 product.

Limitations

The study was conducted on mice, and results may not directly translate to humans.

Participant Demographics

Forty male Swiss mice, 6 weeks old.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6600175

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication